Should FDA Make Patients Care About A Problem If They Don’t Already?
FDA’s Risk Communication Advisory Committee discusses best ways to communicate uncertainty, including how aggressive FDA should be with groups that are not engaged in its messages.
You may also be interested in...
FDA looking for more help from advisory committee on how much information about uncertainty to give as well as how best to communicate it to minority, uneducated groups.
Drug Facts Box format scored well in a broad study, but researchers found it may not be the best format for everyone.
Pink Sheet reporters and editor discuss the new monkeypox vaccine EUA, the potential impact of drug pricing legislation, and how things may have been different if the FDA already had a desired technology upgrade.